First City Capital Management, Inc. Abbott Laboratories Transaction History

First City Capital Management, Inc.

$194 Million
Q3 2024

A detailed history of First City Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, First City Capital Management, Inc. holds 7,243 shares of ABT stock, worth $861,554. This represents 0.43% of its overall portfolio holdings.

Number of Shares

7,243

Previous 8,166 11.3%

Holding current value

$861,554

Previous $848,000 2.71%

% of portfolio

0.43%

Previous 0.48%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$100.07 - $118.13 $92,364 - $109,033	-923 Reduced 11.3%	7,243 $825,000
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $157,642 - $175,968	-1,565 Reduced 16.08%	8,166 $848,000
Q1 2024 May 22, 2024	SELL	$109.52 - $120.96 $123,538 - $136,442	-1,128 Reduced 10.39%	9,731 $1.11 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $57,451 - $70,324	-637 Reduced 5.54%	10,859 $1.2 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $47,765 - $57,310	-500 Reduced 4.17%	11,496 $1.11 Million
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $87,678 - $97,692	-870 Reduced 6.76%	11,996 $1.31 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $56,856 - $66,923	587 Added 4.78%	12,866 $1.3 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $107,702 - $126,352	-1,133 Reduced 8.45%	12,279 $1.35 Million
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $38,704 - $44,812	400 Added 3.07%	13,412 $1.3 Million
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $5,205 - $6,291	-51 Reduced 0.39%	13,012 $1.41 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $20,217 - $24,755	-175 Reduced 1.32%	13,063 $1.69 Million
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $3,966 - $4,388	-34 Reduced 0.26%	13,238 $1.56 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $6,030 - $7,098	-57 Reduced 0.43%	13,272 $1.63 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $10,666 - $12,566	-98 Reduced 0.73%	13,329 $1.55 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.33 Million - $1.45 Million	-12,695 Reduced 48.6%	13,427 $1.7 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $1.17 Million - $1.42 Million	12,745 Added 95.28%	26,122 $2.84 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $39,969 - $51,156	522 Added 4.06%	13,377 $1.22 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $12,564 - $18,372	200 Added 1.58%	12,855 $1.01 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1,227 - $1,331	-15 Reduced 0.12%	12,655 $1.06 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $4,372 - $5,100	-60 Reduced 0.47%	12,670 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $3,648 - $4,401	60 Added 0.47%	12,730 $934,000
Q3 2017 Oct 31, 2017	SELL	$48.06 - $53.64 $4,806 - $5,364	-100 Reduced 0.78%	12,670 $676,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,770	12,770 $621,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Abbott Laboratories Transaction History